To study whether CD11b modulation affects tumor growth and can be a novel therapeutic approach, we utilized the murine LLC transplantable lung cancer model using syngeneic immunocompetent C57BL/6 mice (38) (Figure 2A). Here, ITGAM is linked to lung carcinoma.